DIG
ERNA icon

Dauntless Investment Group’s Eterna Therapeutics ERNA Stock Holding History

Dauntless Investment Group’s Portfolio ERNA Stock Details ERNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$122K Buy
+24,498
New +$391K 0.08% 51

Other funds holding ERNA

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Dauntless Investment Group's ERNA Position: Q1 2026 in Review

Dauntless Investment Group opened a new position in Eterna Therapeutics (ERNA) in Q1 2026: 24,498 shares worth $122K. The stake represents 0.08% of the portfolio and ranks #51 among its holdings.

15 funds tracked by Wall St. Rank hold ERNA as of Q1 2026.

  • Dauntless Investment Group held 24,498 shares of Eterna Therapeutics worth $122K as of Q1 2026.
  • Eterna Therapeutics was a new Dauntless Investment Group position in Q1 2026.
  • Eterna Therapeutics made up 0.08% of Dauntless Investment Group's portfolio in Q1 2026, its #51 holding.
  • 15 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q1 2026.

Based on Dauntless Investment Group's 13F filing for Q1 2026, filed 14 May 2026.